Robot-Assisted Gait Training vs NMES in Parkinson's Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorKanuni Sultan Suleyman Training and Research Hospital

About this trial

This prospective, randomized, assessor-blinded clinical trial aims to compare the effects of robot-assisted gait training and quadriceps neuromuscular electrical stimulation (NMES) when added to a standard exercise rehabilitation program in patients with Parkinson disease.

Participants will be randomly assigned to two parallel groups. Both groups will receive a standard rehabilitation program, while one group will additionally undergo robot-assisted gait training and the other group will receive quadriceps NMES. The interventions will be administered five days per week for six weeks.

Clinical outcomes, including balance, functional mobility, gait performance, and disease severity, will be evaluated at baseline, post-treatment, and follow-up (week 14). In addition, ultrasound-based assessments of quadriceps muscle thickness and cross-sectional area will be performed to investigate muscle adaptations.

The results of this study are expected to provide comparative evidence regarding the effectiveness of these two rehabilitation approaches and contribute to optimizing rehabilitation strategies in Parkinson disease.

Eligibility criteria

Qualifiers

Diagnosis of Parkinson's disease according to established clinical criteria

Age between 40 and 80 years

Hoehn and Yahr stage II-III

Ability to walk independently with or without assistive devices

Disqualifiers

Severe cognitive impairment or inability to follow instructions

Hoehn and Yahr stage IV-V Parkinson's disease

Severe musculoskeletal disorders affecting gait (e.g., advanced osteoarthritis, recent fracture)

History of lower extremity surgery within the last 6 months

Trial design

Treatments tested in this trial

  • Quadriceps Neuromuscular Electrical Stimulation (NMES)
  • robot -assisted gait training

Treatment groups

40 Participants
are divided into 2 treatment groups